TP53 and cancer: Activated AMPK inhibits mTOR complex 1 (mTORC1) (Inoki et al. 2003), induces autophagy (Kim and He 2013), activates p53 (Jones et al. 2005), and degrades a number of important oncogenic proteins (He et al. 2013) in order to achieve its anti-cancer effects.